- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Artificial Pancreas Devices Systems market will register a 12.6% CAGR in terms of revenue, the global market size will reach $ 112.1 million by 2025, from $ 70 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Artificial Pancreas Devices Systems business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Pancreas Devices Systems market by type, application, key manufacturers and key regions and countries.
This study considers the Artificial Pancreas Devices Systems value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Clinics
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Medtronic
Bigfoot Biomedical
Admetsys
Insulet
Beta Bionics
Tandem Diabetes Care
Defymed
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Artificial Pancreas Devices Systems consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Artificial Pancreas Devices Systems market by identifying its various subsegments.
Focuses on the key global Artificial Pancreas Devices Systems manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Artificial Pancreas Devices Systems with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Artificial Pancreas Devices Systems submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artificial Pancreas Devices Systems Consumption 2015-2025
2.1.2 Artificial Pancreas Devices Systems Consumption CAGR by Region
2.2 Artificial Pancreas Devices Systems Segment by Type
2.2.1 Threshold Suspended Device Systems
2.2.2 Hybrid Closed-loop APDS
2.2.3 Other Systems
2.3 Artificial Pancreas Devices Systems Consumption by Type
2.3.1 Global Artificial Pancreas Devices Systems Consumption Market Share by Type (2015-2020)
2.3.2 Global Artificial Pancreas Devices Systems Revenue and Market Share by Type (2015-2020)
2.3.3 Global Artificial Pancreas Devices Systems Sale Price by Type (2015-2020)
2.4 Artificial Pancreas Devices Systems Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Artificial Pancreas Devices Systems Consumption by Application
2.5.1 Global Artificial Pancreas Devices Systems Consumption Market Share by Type (2015-2020)
2.5.2 Global Artificial Pancreas Devices Systems Value and Market Share by Type (2015-2020)
2.5.3 Global Artificial Pancreas Devices Systems Sale Price by Type (2015-2020)
3 Global Artificial Pancreas Devices Systems by Company
3.1 Global Artificial Pancreas Devices Systems Sales Market Share by Company
3.1.1 Global Artificial Pancreas Devices Systems Sales by Company (2018-2020)
3.1.2 Global Artificial Pancreas Devices Systems Sales Market Share by Company (2018-2020)
3.2 Global Artificial Pancreas Devices Systems Revenue Market Share by Company
3.2.1 Global Artificial Pancreas Devices Systems Revenue by Company (2018-2020)
3.2.2 Global Artificial Pancreas Devices Systems Revenue Market Share by Company (2018-2020)
3.3 Global Artificial Pancreas Devices Systems Sale Price by Company
3.4 Global Artificial Pancreas Devices Systems Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Artificial Pancreas Devices Systems Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Artificial Pancreas Devices Systems Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Artificial Pancreas Devices Systems by Regions
4.1 Artificial Pancreas Devices Systems by Regions
4.2 Americas Artificial Pancreas Devices Systems Consumption Growth
4.3 APAC Artificial Pancreas Devices Systems Consumption Growth
4.4 Europe Artificial Pancreas Devices Systems Consumption Growth
4.5 Middle East & Africa Artificial Pancreas Devices Systems Consumption Growth
5 Americas
5.1 Americas Artificial Pancreas Devices Systems Consumption by Countries
5.1.1 Americas Artificial Pancreas Devices Systems Consumption by Countries (2015-2020)
5.1.2 Americas Artificial Pancreas Devices Systems Value by Countries (2015-2020)
5.2 Americas Artificial Pancreas Devices Systems Consumption by Type
5.3 Americas Artificial Pancreas Devices Systems Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Artificial Pancreas Devices Systems Consumption by Regions
6.1.1 APAC Artificial Pancreas Devices Systems Consumption by Regions (2015-2020)
6.1.2 APAC Artificial Pancreas Devices Systems Value by Regions (2015-2020)
6.2 APAC Artificial Pancreas Devices Systems Consumption by Type
6.3 APAC Artificial Pancreas Devices Systems Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Artificial Pancreas Devices Systems by Countries
7.1.1 Europe Artificial Pancreas Devices Systems Consumption by Countries (2015-2020)
7.1.2 Europe Artificial Pancreas Devices Systems Value by Countries (2015-2020)
7.2 Europe Artificial Pancreas Devices Systems Consumption by Type
7.3 Europe Artificial Pancreas Devices Systems Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Artificial Pancreas Devices Systems by Countries
8.1.1 Middle East & Africa Artificial Pancreas Devices Systems Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Artificial Pancreas Devices Systems Value by Countries (2015-2020)
8.2 Middle East & Africa Artificial Pancreas Devices Systems Consumption by Type
8.3 Middle East & Africa Artificial Pancreas Devices Systems Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Artificial Pancreas Devices Systems Distributors
10.3 Artificial Pancreas Devices Systems Customer
11 Global Artificial Pancreas Devices Systems Market Forecast
11.1 Global Artificial Pancreas Devices Systems Consumption Forecast (2021-2025)
11.2 Global Artificial Pancreas Devices Systems Forecast by Regions
11.2.1 Global Artificial Pancreas Devices Systems Forecast by Regions (2021-2025)
11.2.2 Global Artificial Pancreas Devices Systems Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Artificial Pancreas Devices Systems Forecast by Type
11.8 Global Artificial Pancreas Devices Systems Forecast by Application
12 Key Players Analysis
12.1 Medtronic
12.1.1 Company Information
12.1.2 Artificial Pancreas Devices Systems Product Offered
12.1.3 Medtronic Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Medtronic Latest Developments
12.2 Bigfoot Biomedical
12.2.1 Company Information
12.2.2 Artificial Pancreas Devices Systems Product Offered
12.2.3 Bigfoot Biomedical Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Bigfoot Biomedical Latest Developments
12.3 Admetsys
12.3.1 Company Information
12.3.2 Artificial Pancreas Devices Systems Product Offered
12.3.3 Admetsys Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Admetsys Latest Developments
12.4 Insulet
12.4.1 Company Information
12.4.2 Artificial Pancreas Devices Systems Product Offered
12.4.3 Insulet Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Insulet Latest Developments
12.5 Beta Bionics
12.5.1 Company Information
12.5.2 Artificial Pancreas Devices Systems Product Offered
12.5.3 Beta Bionics Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Beta Bionics Latest Developments
12.6 Tandem Diabetes Care
12.6.1 Company Information
12.6.2 Artificial Pancreas Devices Systems Product Offered
12.6.3 Tandem Diabetes Care Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Tandem Diabetes Care Latest Developments
12.7 Defymed
12.7.1 Company Information
12.7.2 Artificial Pancreas Devices Systems Product Offered
12.7.3 Defymed Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Defymed Latest Developments
...
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Artificial Pancreas Devices Systems Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4.
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
